Skip to main content

and
  1. Article

    Open Access

    Design, synthesis, and molecular dynamics simulation studies of some novel kojic acid fused 2-amino-3-cyano-4H-pyran derivatives as tyrosinase inhibitors

    A novel series of kojic acid fused 2-amino-3-cyano-4H-pyran derivatives were synthesized via a multicomponent reaction involving kojic acid, benzyloxy benzaldehyde, and malonitrile as tyrosinase inhibitors. Su...

    Zahra Najafi, Maryam Zandi Haramabadi, Gholamabbas Chehardoli in BMC Chemistry (2024)

  2. Article

    Design, synthesis, molecular modeling and DNA-binding studies of new barbituric acid derivatives

    Cancer disease is develo** all over the world mainly in develo** countries. We should learn more about DNA–ligand interactions to design new drugs that target biological activities like transcription, repl...

    Ahmad Ebadi, Zahra Najafi, Hamed Pakdel-yeganeh in Journal of the Iranian Chemical Society (2022)

  3. No Access

    Article

    An arginine-rich peptide inhibits AChE: template-based design, molecular modeling, synthesis, and biological evaluation

    Life expectancy is growing especially in developed countries. In this regard, aging-associated diseases such as Alzheimer’s disease (AD) are more common. Multi interconnected pathological factors involved in A...

    Dara Dastan, Reza Zhiyani, Kiana Fasihi, Ahmad Ebadi in Journal of Molecular Modeling (2022)

  4. No Access

    Article

    Effect of substitution on the binding affinity of 5-bezylidenebarbituric acid derivatives to ctDNA: in silico and in vitro studies

    Cancer is the second leading cause of death worldwide. Drug researchers have encouraged by the growth of cancer incidence and low efficacy of current treatment to discover new drugs. Targeting specific regions...

    Dara Dastan, Ahmad Ebadi in Journal of Chemical Sciences (2022)

  5. No Access

    Article

    From Venom to AChE Inhibitor: Design, Molecular Modeling, and Synthesis of a Peptidic Inhibitor of AChE

    Alzheimer’s disease (AD) is an irreversible and progressive brain disorder that slowly destroys memory and cognitive skills. The current treatment of AD mainly focused on the restoring of ACh levels through ac...

    Dara Dastan, Kiana Fasihi, Ahmad Ebadi in International Journal of Peptide Research … (2021)

  6. No Access

    Article

    Chemical Composition of the Essential Oils from the Aerial Parts of Eryngium bornmuelleri

    Mahya Soleyman Ekhtiyari, Shirin Moradkhani, Ahmad Ebadi in Chemistry of Natural Compounds (2020)

  7. No Access

    Article

    Kamonolol acetate from Ferula pseudalliacea as AChE inhibitor: in vitro and in silico studies

    Alzheimer’s disease is one of the most common causes of dementia. Acetylcholinesterase has been considered as the main therapeutic target in the treatment of Alzheimer’s disease. Natural products are the riche...

    Dara Dastan, Samane Validi, Ahmad Ebadi in Structural Chemistry (2020)

  8. No Access

    Article

    Insights into the current status of privileged N-heterocycles as antileishmanial agents

    Leishmania, one of the most important neglected tropical diseases, is endemic in several regions of the world and hence regarded as a serious threat to public health. Major difficulties with current chemothera...

    Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, Pari Karami in Molecular Diversity (2020)

  9. No Access

    Article

    Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2

    Phospholipase A2 (PLA2) catalyzes the hydrolysis of phospholipids into arachidonic acid and lysophospholipids. Arachidonic acid is modified by cyclooxygenases into active compounds called eicosanoids that act as ...

    Mohsen Ebrahimi, Omidreza Firuzi, Ramin Miri in Interdisciplinary Sciences: Computational … (2018)

  10. No Access

    Article

    Molecular Modeling of Human CCR2 Receptor within POPC Lipid Bilayer

    Chemokine receptor 2 (CCR2), a G-protein coupled receptor (GPCR), is a critical target for several inflammatory and autoimmune diseases. The main restriction on designing desirable antagonists against CCR2 is ...

    Ahmad Ebadi, Dara Dastan, Mojtaba Azami, Adibe Karimi in Structural Chemistry (2017)

  11. No Access

    Article

    Quantum chemical analysis of potential anti-Parkinson agents

    Monoamine oxidases (MAOs) are amine oxidoreductase falvoenzymes that belong to the integral proteins of the outer mitochondrial membrane. MAO exists in two distinct isoforms; MAO-A and MAO-B. Inhibition of MAO...

    NIMA RAZZAGHI-ASL, SARA SHAHABIPOUR, AHMAD EBADI in Journal of Chemical Sciences (2015)

  12. No Access

    Article

    Molecular docking and quantum mechanical studies on biflavonoid structures as BACE-1 inhibitors

    Beta-site amyloid precursor protein cleaving enzyme (BACE-1) is a well-known therapeutic target for Alzheimer disease (AD) due to its characteristic role in the pathogenesis of AD. Numerous researches have bee...

    Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, Ramin Miri in Structural Chemistry (2015)

  13. No Access

    Article

    Cytotoxic activity assessment and c-Src tyrosine kinase docking simulation of thieno[2,3-b] pyridine-based derivatives

    Thienopyridine derivatives possess various promising biological properties and particularly cytotoxic effect. In vitro cytotoxic activities of some thienopyridine analogous were evaluated by MTT reduction assa...

    Ali Reza Nikkhoo, Ramin Miri, Nahid Arianpour in Medicinal Chemistry Research (2014)

  14. No Access

    Article

    Ab initio modeling of a potent isophthalamide-based BACE-1 inhibitor: amino acid decomposition analysis

    β-Secretase or β-site amyloid precursor protein cleaving enzyme (BACE-1) is a membrane-associated aspartyl protease that catalyzes the first step in the formation of amyloid β plaques responsible for Alzheimer...

    Nima Razzaghi-Asl, Ahmad Ebadi, Najmeh Edraki in Medicinal Chemistry Research (2013)

  15. Article

    Open Access

    Comparative amino acid decomposition analysis of potent type I p38α inhibitors

    p38α is a member of mitogen-activated protein kinases (MAPK) considered as a prominent target in development of anti-inflammatory agents. Any abnormality in the phosphorylation process leads to the different h...

    Ahmad Ebadi, Nima Razzaghi-Asl in DARU Journal of Pharmaceutical Sciences (2013)

  16. No Access

    Article

    Response surface methodology in docking study of small molecule BACE-1 inhibitors

    Computational evaluation of ligand-receptor binding via docking strategy is a well established approach in structure-based drug design. This technique has been applied frequently in develo** molecules of bio...

    Nima Razzaghi-Asl, Ahmad Ebadi, Najmeh Edraki in Journal of Molecular Modeling (2012)